Navigation Links
Nanosys Licenses Nanowire Technology to QuantuMDx Group for Next Generation Diagnostic and Sequencing Technologies
Date:5/11/2009

only seen in the referral laboratory will revolutionize care pathways in the developed world and open up a whole new standard of diagnosis in emerging economies," said Elaine Warburton, chief executive officer of QuantuMDx Group Limited. "Whereas present rapid tests still require confirmation in centralized laboratories, our device will negate this need, therefore reducing health costs and significantly improving the care and experience a patient receives."

QuantuMDx Group Limited's chief scientific officer, Jonathan O'Halloran went on to say, "Our proprietary DNA sequencing technology represents a significant step change in the speed, accuracy and read lengths presently available with today's 'next-gen' sequencers. Our patented dual approach to sequence both in parallel and long read lengths, using low cost equipment, will provide the tools necessary for the genomic medicine era."

Andrew Filler, general counsel and vice president of intellectual property at Nanosys, commented, "We are pleased to add QMDx Group as the latest licensee to our broad and deep intellectual property around nanowires for biosensor devices. Through continued R&D and licensing efforts, Nanosys is expanding the transformative applications of nanotechnology in the marketplace."

About Nanosys, Inc.

Nanosys, Inc. is a leader in the development of nanotechnology enabled products utilizing high performance inorganic nanostructures. Nanosys has built one of the broadest technology platforms in the industry with over 650 patents and patent applications covering fundamental areas of nanotechnology. Based in Palo Alto, California and privately held, Nanosys collaborates with industry leaders to develop revolutionary high-value, high-performance products for the life sciences, computing, lighting, renewable energy, and defense industries. Additional information on Nanosys can be found at '/>"/>

SOURCE Nanosys Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3

Related biology technology :

1. Global Med Technologies(R) Licenses 90th Site in the Southeastern U.S.
2. Implicit Licenses Clinical Stage Antibody Program From Lilly
3. Artemis Health Licenses Prenatal Cell-Free DNA Analysis Technology from Stanford University
4. BioWa Licenses POTELLIGENT(R) Technology to GlaxoSmithKline for Use in Antibody Development and Commercialization
5. Arizona Heart Innovative Technologies Licenses New Endovascular Device
6. Stem Cell Sciences Licenses Stem Cell Technology to Leading Provider of Genetically Modified Models for Pharmaceutical Research
7. Onyx Pharmaceuticals Licenses Rights to Novel Targeted Oncology Agent From BTG International
8. MedImmune Licenses Reverse Genetics Technology to Hungarys Omninvest for Use in Influenza Vaccine Development and Production
9. Access Pharmaceuticals Licenses MuGard to Milestone Biosciences, LLC for North America
10. Interleukin Genetics Licenses its PST(R) Genetic Test to OralDNA Labs
11. Addrenex Pharmaceuticals Licenses New Compound to Sciele Pharma for the Treatment of Hypertension and Other Potential Indications
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/14/2014)... 2014 Carahsoft and CDS Federal Services ... 2014 at 2pm EST (11am PST), “Natural Language Processing: ... on how technology can turn raw, heterogeneous data into ... agencies. The online webinar will last approximately one hour. ...
(Date:1/14/2014)... a leading provider of strategic communications services to corporations and organizations ... the United States and Europe ... is returning to the firm,s Washington, D.C. ... than two years of service as Associate Commissioner for the Office ...
(Date:1/14/2014)... NY (PRWEB) January 14, 2014 EquitiesIQ, ... Alliqua, Inc. (OTCQB: ALQA). Alliqua is an emerging biomedical ... serve the wound care market. , Free report download: ... restructured with a seasoned management team and Board, which ...
(Date:1/14/2014)... BETHESDA, Md. , Jan. 14, 2014  Organovo ... institutes from the National Institutes of Health (NIH) to ... more effective treatments to patients on a faster timeline. ... Translational Sciences (NCATS) and the National Eye Institute (NEI) ...
Breaking Biology Technology:Webcast - Natural Language Processing: Converting Raw Data into Actionable Knowledge – Hosted by Carahsoft and CDS Federal Services 2Former FDA Associate Commissioner Returns To 3D Communications 2EquitiesIQ Initiates Coverage of Alliqua, Inc. 2EquitiesIQ Initiates Coverage of Alliqua, Inc. 3Organovo Announces Collaboration with National Institutes of Health 2Organovo Announces Collaboration with National Institutes of Health 3
... Biopharmaceutical manufacturers,responsible for an extensive repertoire ... and vaccines -- are faced with,many aspects ... product being assessed. A,new whitepaper from Microtest ... requirements associated with the aseptic processing of,a ...
... FRANCISCO, Aug. 12 VIA Pharmaceuticals,Inc. (Nasdaq: VIAP ... for the treatment of cardiovascular disease, announced today that,James ... of VIA,will present a company update at the Fourth ... Tuesday, August 19, 2008 at the Loews Lake,Las Vegas ...
... Aug. 12 DSM Biologics and MorphoSys,AG ... TecDAX) today,announced the signing of a Biopharmaceutical ... of MOR202. MOR202 is a,fully human HuCAL(R) ... the treatment of multiple myeloma. DSM Biologics ...
Cached Biology Technology:White Paper Explains Aspects of Testing From Purified Bulk Drug Substance to Sterile Liquid Final Drug Product 2VIA Pharmaceuticals to Present at Fourth Annual Noble Financial Equity Conference 2DSM Biologics and MorphoSys AG to Manufacture Fully Human Antibody 2DSM Biologics and MorphoSys AG to Manufacture Fully Human Antibody 3
(Date:4/23/2014)... School of Public Health-Bloomington has bolstered the link between ... strong association between heme iron, found only in meat, ... found that heme iron consumption increased the risk for ... was found between nonheme iron, which is in plant ... The study was published online ahead of print in ...
(Date:4/23/2014)... their mid-thirties and forties, face a devastating prognosis: ... decades. "Mutant" protein clusters, long blamed for the ... primary focus of therapies in development by pharmaceutical ... Gerardo Lederkremer and Dr. Julia Leitman of Tel ... in collaboration with Prof. Ulrich Hartl of the ...
(Date:4/23/2014)... University of Toronto Scarborough research shows that male black ... virgins a rare example of mate preference by ... UTSC post-doc Emily MacLeod and Maydianne Andrade, a professor ... controlled field studies and the wild that males overwhelmingly ... found male black widows can tell whether a potential ...
Breaking Biology News(10 mins):Study: Iron consumption can increase risk for heart disease 2On the defensive 2On the defensive 3Picky male black widow spiders prefer well-fed virgins 2
... colleagues have received a National Institutes of Health grant to ... messaging system affect cellular processes. ,Matthew Bennett, ... more than a million dollars over five years to gather ... goal is to create techniques to generate and analyze models ...
... German . Until recent decades the Atlantic ... to present-day Argentina. In the 1970s, after years of deforestation, ... cattle pastures. This study reveals an unexpected aspect of deforestation. ... show that the common practice of slash and burn left ...
... Science Exchange, in partnership with the open-access publisher PLOS ... of the Reproducibility Initiative a new ... their critical research findings. "In the ... a lot of public attention, particularly in the context ...
Cached Biology News:NIH backs Rice University study of delay in gene transcription networks 2Marine research in the Brazilian rainforest 2Marine research in the Brazilian rainforest 3Reproducibility Initiative to increase the value of biomedical research 2Reproducibility Initiative to increase the value of biomedical research 3
HiTrap NHS-activated HP, 1 x 5 ml. Category: Chromatography Systems & Accessories, Systems....
Human OSCAR MAb (Clone 259501)...
Human/Mouse G9a/EHMT2 MAb (Clone A8620A) Keywords: Eu-HMTase2...
Human M-CSF...
Biology Products: